Patent

NMDA Antagonists - New selective compounds to the NR2B subunit with high affinity

he NMDA receptor, an ion channel consisting of several protein subunits, is involved in the pathophysiology of chronic neurodegenerative diseases, depression, pain and alcoholism. Different subtypes of NMDA receptors can be categorized based on their subunit composition. The NR2B subunit expression is mostly localized in forebrain regions including cortex, hippocampus and striatum.

Contact

PROvendis GmbH
Dipl.-Ing. Alfred Schillert
Phone: +49 (0)208/94105 10
Email: kontakt@provendis.info
Autor: Constanze Hasenbein, Dipl.-Biol., Tel.: +49 (0)208/94105-41

Further information: PDF

Topic: Biotechnology, New Materials and Chemistry, Health and Medicine
Source: TechnologieAllianz e. V.

The initiative The topics The regions The networks The service press releases Order Service newsletter subscription news announcements patents Events Event Review	News
	Patent NMDA Antagonists - New selective compounds to the NR2B subunit with high affinity he NMDA receptor, an ion channel consisting of several protein subunits, is involved in the pathophysiology of chronic neurodegenerative diseases, depression, pain and alcoholism. Different subtypes of NMDA receptors can be categorized based on their subunit composition. The NR2B subunit expression is mostly localized in forebrain regions including cortex, hippocampus and striatum. Contact PROvendis GmbH Dipl.-Ing. Alfred Schillert Phone: +49 (0)208/94105 10 Email: kontakt@provendis.info Autor: Constanze Hasenbein, Dipl.-Biol., Tel.: +49 (0)208/94105-41 Further information: PDF Topic: Biotechnology, New Materials and Chemistry, Health and Medicine Source: TechnologieAllianz e. V.	Print page Back